Monday, April 28, 2025

Latest

$BABY: Weak Demand For IPO Caused Debuting Nasdaq Stock To Fail On Trading Day

PishPosh, a small baby-goods shop that wanted to list under the ticker BABY, had its initial public offering postponed due to little demand, in a rare occurrence of a stock failing to begin trading on the day of its scheduled market debut.

About 3:38 p.m. ET on Wednesday, Nasdaq said in an advisory that the IPO had been “voluntarily postponed at the direction of the underwriter,” adding that all Nasdaq systems were operational regularly. Stocks in an IPO often begin trading in the morning or early afternoon.

According to a securities filing, Boustead Securities was the primary underwriter of the IPO.

PishPosh, based in New Jersey, announced Wednesday morning that it had priced its shares at $5 in the IPO, with around 1.82 million common shares intended to raise $9.1 million for the company.

But, demand for the stock was insufficient for the shares to begin trading at that price. According to a person familiar with the case who told The Wall Street Journal, the indicative price in the opening auction—an estimate of where the stock will begin trading based on demand from buyers and sellers—remained much below $5 in the hours before the deal was withdrawn.

PishPosh is yet another story amongst the declining IPO market. The number of firms that filed for an initial public offering in 2022 decreased by nearly half from the previous year’s record pace.

In 2022, there were 1,671 IPOs launched globally, compared to 3,260 in 2021. According to S&P Global Market Intelligence statistics, the total amount issued in those IPOs in 2022 fell to $179.73 billion, down from $626.56 billion in 2021. The poor performance of shares in 2022, aggressive rate hikes by central banks, and fears of a worldwide recession all stifled activity in public markets.

In the fourth quarter of 2022, 404 IPOs were issued globally, almost the same amount as in the previous two quarters. The value of the offerings totaled $35.70 billion, the lowest amount offered in a period since the first quarter of 2019, when 265 IPOs totaled $18.90 billion.

In comparison, 916 IPOs worth $150.28 billion were launched in the fourth quarter of 2021.

IPO activity in the US contributed to much of the market cooldown. Twenty IPOs in the US were launched during Q4 2022, worth $3.02 billion in all. This compares to 234 IPOs totaling $65.44 billion in the same quarter last year.

For the whole year, there were 149 IPOs in the United States in 2022, totaling $20.79 billion, compared to 908 IPOs in 2021, totaling $282.66 billion.


Information for this briefing was found via The Wall Street Journal, SPGlobal, and the sources mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Bell Q3 Earnings: Massive Impairments. Guidance Cuts. A Mess.

Alamos Gold Q3: Record Revenue & Production Amid Rising Costs

The Junior Mining Market Is Back

Recommended

Germany Looks To Modernize Military Recruitment But Stops Short of Conscription

First Majestic Silver Posts Topline Revenue Of $146.1 Million In Q3 2024

Related News

Reddit: The High Level Details Of The IPO

The popular online platform Reddit has revealed its intention to go public on the New...

Friday, February 23, 2024, 08:05:41 AM

Wealth Management SPAC Everest Consolidator Acquisition Prices US$150 Million IPO

Special purpose acquisition company Everest Consolidator Acquisition Corporation (NYSE: MNTN.U) went public on Wednesday on...

Friday, November 26, 2021, 01:54:00 PM

Hemp Manufacturer Hempacco Prices Downsized US$6 Million IPO

Hemp manufacturing company Hempacco Co., Inc. (Nasdaq: HPCO) started trading its shares on the Nasdaq...

Tuesday, August 30, 2022, 02:19:00 PM

Tampa Bay Rays Owner-Led SPAC Counter Press Acquisition Prices US$75 Million IPO

Special purpose acquisition company Counter Press Acquisition Corp. (Nasdaq: CPAQU) started trading publicly on the...

Thursday, February 10, 2022, 02:21:00 PM

Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today...

Friday, July 30, 2021, 11:56:00 AM